Pegylatedinterferon相关论文
...
The impact of pegylated interferon for treament of HCV in far-stage liver cancer:a systematic review
Objective: Systematic evaluation of the impact of pegylated interferon in the long-term treatment of chronic hepatitis C......
...
2011年5月，2种 HCV NS3蛋白酶抑制剂口服药--特拉泼维（telaprevir）和博赛泼维（boceprevir）获美国 FDA批准上市。此后，HCV-1型慢性丙型肝......
目的 观察慢性丙型病毒性肝炎治疗效果.方法 回顾性分析120例慢性丙型病毒性肝炎的感染途径、丙型肝炎病毒(HCV)载量及其基因分型；......
目的观察慢性乙型肝炎(CHB)患者接受聚乙二醇干扰素α-2a(PEG-IFNα-2a)治疗后舌脉象参数的变化，探讨其在PEG-IFNα-2a治疗慢性乙型......
More than 170 million people worldwide have chronic hepatitis C. Acute hepatitis C is rarely diagnosed because it is com......
Clearance of hepatitis C virus after living-donor liver transplantation in spite of residual viremia
Interferon (IFN) therapy is the only treatment strategy for hepatitis C virus (HCV) infection after liver transplantatio......
Anemia of diverse etiology is a common complication of chronic liver diseases. The causes of anemia include acute or chr......
Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response
AIM:To investigate relapse predictors in chronic hepatitis C (CHC) patients with end-of-treatment response (ETR), after ......
Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic geno
...
Combination of peg ylated interferon and lamivudine for patients with chronic hepatitis B who have f
BACKGROUND: Treatment of chronic hepatitis B (CHB) alone with interferon or lamivudine alone or in combination is effect......
Severe immune thrombocytopenia after peg-interferonalpha2a,ribavirin and telaprevir treatment comple
Mild to moderate autoimmune thrombocytopenia （AITP）is a common finding in patients receiving interferonbasedantiviral trea......
